Phase 2 Study of Talimogene Laherparepvec in Combination with Pembrolizumab in Subjects with Unresectable/Metastatic Stage IIIB-IVM1d Melanoma Who Have Progressed on Prior Anti PD-1 Based Therapy
- Haydon, Andrew (Primary Chief Investigator (PCI))
- Hawkins, Cheryl-Ann (Project Manager)
Project: Research